Back to Awarded Treatment Trials
Awarded Trial: 11T-013
Grant ID
11T-013
Illness
Schizophrenia
Primary Drug/Intervention
minocycline
Primary Dosage
200 mg/day
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Fekadu
Sample Size
150
Duration of Study Period for Each Subject
8 weeks
Outcome Measurements
Change in symptom severity meaured by PANSS
Results
N/A
Publication
N/A
Link
N/A
PI Name
Abebaw Fekadu
Degree
MD
Center
School of Medicine, College of Health Sciences
Institution
Addis Ababa University
Address
Department of Psychiatry
City or Town
N/A
State or Province
N/A
Zip or Postal Code
N/A
Country
N/A
Email Address
abe.wassie@kcl.ac.uk